Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VR506 in severe persistent asthma requiring oral corticosteroids
NCT01720069Phase 3Completed
- Sponsor
- Vectura
- Start
- Oct 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of VR506 in asthma, sponsored by Vectura. Started Oct 2012; status: completed.
02
Drugs
VR506
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01720069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720069.